NDC 55154-1487

Hydralazine

Hydralazine

Hydralazine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Hydralazine Hydrochloride.

Product ID55154-1487_74970c8e-d02a-4289-8ce2-cbfd32e8dfaa
NDC55154-1487
Product TypeHuman Prescription Drug
Proprietary NameHydralazine
Generic NameHydralazine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2009-09-14
Marketing CategoryANDA / ANDA
Application NumberANDA088468
Labeler NameCardinal Health
Substance NameHYDRALAZINE HYDROCHLORIDE
Active Ingredient Strength50 mg/1
Pharm ClassesArteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 55154-1487-0

10 BLISTER PACK in 1 BAG (55154-1487-0) > 1 TABLET in 1 BLISTER PACK
Marketing Start Date2009-09-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55154-1487-0 [55154148700]

Hydralazine TABLET
Marketing CategoryANDA
Application NumberANDA088468
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-09-14

Drug Details

Active Ingredients

IngredientStrength
HYDRALAZINE HYDROCHLORIDE50 mg/1

OpenFDA Data

SPL SET ID:18297bc9-5ea2-48ff-9ba4-e9b9492e9cdc
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 905225
  • 905395
  • UPC Code
  • 0055154148702
  • 0055154149006
  • Pharmacological Class

    • Arteriolar Vasodilation [PE]
    • Arteriolar Vasodilator [EPC]
    • Arteriolar Vasodilation [PE]
    • Arteriolar Vasodilator [EPC]

    NDC Crossover Matching brand name "Hydralazine" or generic name "Hydralazine"

    NDCBrand NameGeneric Name
    55154-1487HydralazineHydralazine
    55154-1490HydralazineHydralazine
    70518-1581HydralazineHYDRALAZINE HYDROCHLORIDE
    75834-126HydralazineHYDRALAZINE HYDROCHLORIDE
    75834-127HydralazineHYDRALAZINE HYDROCHLORIDE
    75834-128HydralazineHYDRALAZINE HYDROCHLORIDE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.